Order before 10:00 | Shipped the same dayLab tested quality
4.8 · 17,382 verified reviews

Broad Spectrum CBD: What The Term Covers

Still life with a Cibdol product introducing What Is Broad Spectrum CBD
Cibdol · Broad Spectrum CBD: What The Term Covers

Definition

Full spectrum keeps the cannabinoid range as extraction leaves it, trace THC included. Broad spectrum starts from the same hemp extract and takes the THC out, with the other cannabinoids meant to stay. CBD isolate goes one step further and keeps a single compound.

Three Names, One Plant

  1. Full spectrum. The extract keeps the cannabinoid range the plant produced, trace THC included, within the legal limit of the market it's sold in. Dozens of cannabinoids have been described in cannabis, and the same plant tissue also produces terpenes and flavonoids [1].
  2. Broad spectrum. The same hemp extract, with one extra processing step: the THC comes out, the rest of the cannabinoid profile is meant to remain. How far down the THC goes depends on the method used and on the detection limit of the laboratory that measured it.
  3. CBD isolate. One compound, purified until nothing else is left: no terpenes, no flavonoids, no minor cannabinoids. What you gain is a very simple label. What you leave behind is everything else the plant made.
  4. The middle option is the vague one. Full spectrum and isolate more or less describe themselves. Broad spectrum describes a subtraction, and the size of that subtraction only exists as a figure on a lab report.
  5. A wording note worth keeping. Broad spectrum is a market term, not a legal category. It isn't tightly defined in EU law or UK law, so two products carrying the phrase can be built to different standards.
  6. Which makes the practical question narrower than the naming debate. Not which of the three sounds best, but which bottle arrives with an analysis you can read, naming each cannabinoid and its measured amount for that batch.

A Phrase With No Legal Line

Nobody has drawn that line for you. Broad spectrum isn't tightly defined in EU law or in UK law, so there's no threshold to point at and no wording rule a producer has to meet. The phrase can sit on a product where THC was reduced, and on a product where it was pushed below what the equipment could see. Both say broad spectrum. Neither is lying about the words, because the words don't commit to a number. That moves the whole question onto documentation. Not the front of the box. The analysis for the batch in your hand. Since 2014, that's been our own standard: every batch independently analysed, and cannabinoid content set against what the label claims, before the seal is broken.

What A Batch Analysis Names

A report turns adjectives into figures. It lists the cannabinoids found, the amount of each, the batch code and the date of testing. THC removed becomes THC measured at a stated value, with the laboratory's detection limit written beside it. If a producer can't show you that document for the batch you're buying, broad spectrum stays a marketing word. If they can, you don't have to trust the phrase at all. You can read straight past it.

Where The Research Stops Short

Extract Types In Human Studies

Chemistry separates the three types cleanly. Human research can't do the same yet. Direct comparisons of extract types in people are limited, so the distance between a full spectrum extract, a broad spectrum one and an isolate is easier to describe on a certificate than to quantify in a trial. What has been described in detail is the plant. Russo's 2011 paper set out dozens of cannabinoids identified in cannabis and noted that the same plant tissue produces terpenes and flavonoids alongside them [1]. That's botany and chemistry. It isn't a measured comparison of three finished products, and a certificate answers a composition question rather than a comparison one.

Millar 2018 On Cannabidiol In People

Before extract type, there's a more basic gap. Millar's 2018 systematic review gathered the human data on cannabidiol pharmacokinetics, meaning absorption, distribution and clearance: what the body does with the compound once it's taken. Across the studies available, those parameters were inconsistently documented [2]. So the honest position on broad spectrum is a modest one. We can say what's chemically in a bottle, batch by batch, with a name and a number for each cannabinoid. We can't tell you from published human research how one extract type compares with another. When better data arrives, the description changes with it.

What Our Own Range Holds

Straight answer, because it's usually the next question. There's no broad spectrum product in the Cibdol range at the moment. The oils and the capsules are full spectrum, and the box print says so in as many words: Full spectrum 2.0 with terpenes and flavonoids. That's a formulation choice we can document, not a verdict on which type suits anyone. If broad spectrum is specifically what you're after, look for a producer who publishes a batch analysis with THC stated as a figure and the detection limit written next to it. Anything less specific is a phrase, not a measurement.

  • The oils and capsules in the range are full spectrum.
  • The box carries the line Full spectrum 2.0 with terpenes and flavonoids.
  • There's no broad spectrum option in the range as it currently stands.
  • Every batch goes out with an independent analysis behind it.
  • You can compare cannabinoid content against the label before the bottle is opened.
  • We've been working with cannabinoids since 2014, which is where the batch-by-batch habit comes from.

Reading The Bottle, Not The Adjective

The word on the front is the least informative thing on the packaging. Broad spectrum tells you an intention: THC out, other cannabinoids in. It doesn't tell you the figure, the method, or who did the measuring. So ask for the analysis of the batch you're buying, and check three things on it. The batch code matches the bottle. The date belongs to this production run, not to one from two years ago. And THC appears as a number with a detection limit, rather than as an empty space.

Then keep expectations where the evidence puts them. Human comparisons between extract types are limited, and even for cannabidiol on its own, Millar's 2018 review found the pharmacokinetic data in people inconsistently documented across the studies available [2]. Individual responses vary. No one can hand you a published trial that ranks the three extract types in order.

If you take prescription medication or you're managing a health condition, run it past your doctor before you add anything new. And if you're comparing labels this evening, compare the certificates instead of the front panels. The chemistry is written down and dated. The marketing isn't.

Frequently Asked Questions

Is broad spectrum the same as THC-free?
Not automatically. The term isn't tightly defined in EU or UK law, so the actual THC figure depends on the removal method and on the detection limit of the laboratory doing the measuring. The batch analysis is where that becomes a number instead of a phrase.
How many cannabinoids are we talking about in hemp?
Dozens have been described in cannabis, and Russo's 2011 paper also noted that the same plant tissue produces terpenes and flavonoids alongside them. A batch report shows which of those cannabinoids were measured in a specific production run, and in what amount.
Which extract type does the research support best?
Direct comparisons between extract types in people are limited. Millar's 2018 systematic review looked at cannabidiol pharmacokinetics in humans and found absorption, distribution and clearance inconsistently documented across the studies available, so there's no published ranking to hand you.
What does Cibdol currently make?
Full spectrum oils and capsules, with the line Full spectrum 2.0 with terpenes and flavonoids printed on the box. There's no broad spectrum option in the range as it stands. Every batch is independently analysed, a standard we've kept since 2014.

About this article

Luke Sholl has been writing about cannabinoids, CBD, and the broader benefits of nature since 2011. His background includes first-hand cannabis cultivation experience spanning the full seed-to-harvest lifecycle across so

This wiki article was drafted with AI assistance and reviewed by Luke Sholl, CBD & wellness writer. Editorial oversight by Joshua Askew.

Editorial standardsAI use policy

Medical disclaimer. This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before use of any substance.

Last reviewed 29 серпня 2026 р.

References (2)

  1. [1]Russo, E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. DOI: https://doi.org/10.1111/j.1476-5381.2011.01238.x
  2. [2]Millar, S.A. et al. (2018). A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. DOI: https://doi.org/10.3389/fphar.2018.01365

Spot an error? Contact us

Related Articles

Still life with a Cibdol product introducing Does CBG Make You Sleepy
cluster

Does CBG Make You Sleepy? What's Actually on Record

The idea that cannabigerol brings on drowsiness is widely repeated, but the 2021 review by Nachnani and Barrett describes receptor sites rather than sensations in volunteers. The same thing happened to CBN, and Corroon traced it in 2021.

Still life with a Cibdol product introducing THCA vs THC: One Carboxyl Group
cluster

THCA vs THC: A Single Carboxyl Group Apart

One carboxyl group separates the acid form found in the plant from the neutral compound most people talk about. Here is what happens when it goes, and why two lab figures from one plant are not a contradiction.

Still life with a Cibdol product introducing What Is THCP
cluster

THCP: A Cannabinoid With Two Extra Carbons

Tetrahydrocannabiphorol turned up in an Italian medicinal cannabis variety in December 2019, in work led by Cinzia Citti [1]. Here is what that report actually records, and where our own range sits.

Still life with a Cibdol product introducing What CBD Research Actually Covers
cluster

CBD Research: What the Human Data Covers

A calm look at what has actually been measured in cannabidiol studies, where the published record thins out, and what to check before you believe a claim.

Still life with a Cibdol product introducing Serotonin: What It Is, Where It Lives
cluster

Serotonin, 5-HT and the One Cannabinoid Link on Record

5-HT is not one receptor but at least seven families of them, each split into subtypes. Here is what that means for reading claims, and what the 2005 in vitro report on cannabidiol at 5-HT1a does and does not cover [1].

Still life with a Cibdol product introducing PEA (Palmitoylethanolamide): Anandamide's Chemical Relative
cluster

PEA and Anandamide: A Family Resemblance in Chemistry

Palmitoylethanolamide shares a chemical class and a clearance route with anandamide. Here is what that family resemblance settles, and what it deliberately leaves open.

Still life with a Cibdol product introducing How the Endocannabinoid System Was Discovered
cluster

The Endocannabinoid System in Six Papers, 1964 to 1995

The structure of THC was published in 1964, the first cannabinoid receptor in 1990, anandamide in 1992. Six reports, thirty-one years, and a name that runs backwards.

Still life with a Cibdol product introducing What Is Clinical Endocannabinoid Deficiency (CECD)?
cluster

2016: What Clinical Endocannabinoid Deficiency (CECD) Actually Means

CECD is a testable idea about underactive endocannabinoid signalling, set out most clearly in a 2016 paper by Russo [1]. Here is what that paper names, and where the record stops.

Still life with a Cibdol product introducing What Are Endocannabinoids?
cluster

Endocannabinoids: The Cannabinoids The Body Builds Itself

Anandamide in 1992, 2-AG in 1995: two named molecules, two clearing enzymes. A calm walk through what the cited papers put on record, and where the record stops.